Dolby Laboratories (NYSE:DLB) EVP Mark Andrew Sherman sold 10,000 shares of the company’s stock in a transaction on Friday, January 12th. The shares were sold at an average price of $65.00, for a total value of $650,000.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Mark Andrew Sherman also recently made the following trade(s):

  • On Tuesday, December 19th, Mark Andrew Sherman sold 4,594 shares of Dolby Laboratories stock. The stock was sold at an average price of $62.45, for a total transaction of $286,895.30.
  • On Wednesday, October 18th, Mark Andrew Sherman sold 7,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $60.00, for a total transaction of $420,000.00.

Dolby Laboratories (NYSE:DLB) traded down $2.24 during midday trading on Tuesday, reaching $63.11. 603,600 shares of the company’s stock traded hands, compared to its average volume of 278,952. Dolby Laboratories has a 12-month low of $47.19 and a 12-month high of $65.56. The stock has a market cap of $6,480.00, a PE ratio of 32.53, a price-to-earnings-growth ratio of 2.43 and a beta of 0.85.

Dolby Laboratories (NYSE:DLB) last posted its quarterly earnings data on Wednesday, October 25th. The electronics maker reported $0.45 earnings per share for the quarter, topping the consensus estimate of $0.27 by $0.18. Dolby Laboratories had a net margin of 18.66% and a return on equity of 10.62%. The firm had revenue of $242.05 million for the quarter, compared to analysts’ expectations of $244.80 million. During the same period in the previous year, the company posted $0.37 EPS. The company’s quarterly revenue was up 3.9% compared to the same quarter last year. research analysts expect that Dolby Laboratories will post 2.24 earnings per share for the current year.

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in shares of Dolby Laboratories by 9.8% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,331 shares of the electronics maker’s stock valued at $114,000 after acquiring an additional 209 shares in the last quarter. The Manufacturers Life Insurance Company grew its holdings in shares of Dolby Laboratories by 25.5% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 3,564 shares of the electronics maker’s stock valued at $174,000 after acquiring an additional 725 shares in the last quarter. Berkshire Asset Management LLC PA purchased a new position in shares of Dolby Laboratories during the 3rd quarter valued at $200,000. CIBC Asset Management Inc purchased a new position in shares of Dolby Laboratories during the 3rd quarter valued at $204,000. Finally, Campbell & CO Investment Adviser LLC purchased a new position in shares of Dolby Laboratories during the 3rd quarter valued at $231,000. Hedge funds and other institutional investors own 52.53% of the company’s stock.

Several equities analysts have weighed in on the stock. B. Riley cut shares of Dolby Laboratories from a “buy” rating to a “neutral” rating and set a $63.00 price objective on the stock. in a research report on Tuesday. Zacks Investment Research cut shares of Dolby Laboratories from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 31st. One investment analyst has rated the stock with a sell rating, three have given a hold rating and one has assigned a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus target price of $59.33.

ILLEGAL ACTIVITY WARNING: “Mark Andrew Sherman Sells 10,000 Shares of Dolby Laboratories (DLB) Stock” was originally published by American Banking News and is owned by of American Banking News. If you are viewing this story on another domain, it was stolen and reposted in violation of US & international copyright and trademark law. The legal version of this story can be read at https://www.americanbankingnews.com/2018/01/16/mark-andrew-sherman-sells-10000-shares-of-dolby-laboratories-dlb-stock.html.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc designs and manufactures audio and imaging products for the cinema, television, broadcast and entertainment industries. Its products for cinema include Digital Cinema Servers and Cinema Audio Products, and broadcast and other include Dolby Conference Phone and Other Products. It offers services to support theatrical and television production for cinema exhibition, broadcast and home entertainment, including equipment training and maintenance, mixing room alignment and equalization, as well as audio, color and light image calibration.

Insider Buying and Selling by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.